PATENT CLAIM ANALYSIS

Application Number: 15997000
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "665000"]

Abstract:
The present invention relates to compositions of cysteamine or a derivative thereof for use in the treatment or prophylaxis or a disease or condition associated with neutrophil elastase activity. The compositions can be administered, e.g., by inhalation, intravenously, or topically, as appropriate.

Claim (Index 8):
Use of cysteamine or a derivative thereof as a neutrophil elastase inhibitor.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.32432
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13277942', '14332829', '12956576', '14353273', '14528511']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7368657076919922
- 35 USC 102 Novelty (BERT): 0.465162366240137
- Combined Prediction Score: 0.7096953735468068
- Mean Citation Score: 107.9176882
- Max Citation Score: 110.785706
- Similarity Product: 79.30844321761656

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test